GTBP
GT Biopharma·NASDAQ
--
--(--)
--
--(--)
GTBP Filings
Filing Date
Form Description
Form Type
2026-03-06
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Financials
2026-03-06 · Financials
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2026-03-06
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Financials
2026-03-06 · Financials
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2026-03-02
Form 8-K - Current report
Key Events
2026-03-02 · Key Events
Form 8-K - Current report
2026-03-02
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Financials
2026-03-02 · Financials
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026-02-02
Form EFFECT - Notice of Effectiveness
2026-02-02 ·
Form EFFECT - Notice of Effectiveness
2026-01-30
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-01-30 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-01-21
Form S-1 - General form for registration of securities under the Securities Act of 1933
2026-01-21 ·
Form S-1 - General form for registration of securities under the Securities Act of 1933
2026-01-08
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-01-08 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-12-03
Form EFFECT - Notice of Effectiveness
2025-12-03 ·
Form EFFECT - Notice of Effectiveness
2025-12-02
Form CORRESP - Correspondence
SEC Inquiries
2025-12-02 · SEC Inquiries
Form CORRESP - Correspondence
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
